EIP Pharma Receives $20.5 Million Series B to Fund Alzheimer's Candidate

EIP Pharma, announced  on 5/16/18 the successful completion of a $20.5 million Series B financing. The Series B financing was led by Access Industries. This new round follows a Series A financing in 2017 funded by EIP senior leadership and other healthcare industry executives.